Molecules 2017, 22, 684
8 of 12
5-(2,4-Di(piperidin-1-yl)phenyl)-4-nitrobenzo[c][1,2,5]oxadiazole (14): eluent: ethyl acetate/dichloromethane
1
2/8; 38%; brown solid, m.p.: >120 ◦C (dec); IR (v, cm−1): 1598, 1506, 1319, 1235; H-NMR (CDCl3,
400 MHz, 25 ◦C):
δ
(ppm): 7.96 (d, J = 9.0 Hz, 1H); 7.67 (d, J = 9.0 Hz, 1H); 7.10 (br.s, 1H); 6.63 (br.s,
2H); 3.30 (br.s, 4H); 2.84 (br.s, 4H); 1.73 (br.s, 4H); 1.64 (br.s, 4H); 1.43 (br.s, 4H); 13C-NMR (CDCl3:
100.56 MHz, 25 ◦C):
δ (ppm): 154.2; 153.5; 149.0; 144.2; 140.9; 137.2; 130.8; 122.5; 121.3; 118.7; 110.0;
106.1; 53.5; 49.3; 29.7; 25.9 (two signals overlapped); 24.1; ESI-MS (m/z): 408 [M + H]+, 430 [M + Na]+,
446 [M + K]+ HRMS (ES+) m/z: [M + H]+ calculated for C22H26N5O3 408.2036 found 408.2033.
5-(2,4-Di(pyrrolidin-1-yl)phenyl)-4-nitrobenzo[c][1,2,5]oxadiazole (16): eluent: ethyl ether/petroleum light
◦
1
7/3; yield 50%; orange solid, m.p.: >115 C (dec); IR (v, cm−1): 1601, 1503, 1321, 1233; H-NMR
(CDCl3, 400 MHz, 25 ◦C):
J = 8.6 Hz, 1H); 6.34–6.25 (m; 2 H, two signals overlapped); 3.42 (t, J = 6.5 Hz, 4H), 3.16 (s; 2H); 3.04 (s,
2H) 2.08 (t, J = 6.48 Hz, 4H); 1.83 (t, J = 6.33 Hz, 4H); 13C-NMR (CDCl3: 100.56 MHz, 25 ◦C):
(ppm):
δ (ppm): δ, ppm: 7.89 (d, J = 9.4 Hz, 1H); 7.62 (d, J = 9.4 Hz, 1H); 7.05 (d,
δ
149.4; 148.9; 144.3; 142.2; 136.5; 132.1; 118.9; 105.8; 100.8; 51.7; 50.0; 25.6; 25.2; (selected data); ESI-MS
(m/z): 380 [M + H]+, 402 [M + Na]+; HRMS (ES+) m/z: [M + H]+ calculated for C20H22N5O3 380.1723
found 380.1723.
N1,N1,N3,N3-Tetramethyl-4-(4-nitrobenzo[c][1,2,5]oxadiazol-5-yl)benzene-1,3diamine (17): eluent: ethyl
ether/petroleum light 3/7;yield 36%; brown solid, m.p.: >130 ◦C (dec); IR (v, cm−1): 1604, 1498, 1315,
◦
1237;1H-NMR (CDCl3, 400 MHz, 25 C):
δ
(ppm): 77.94 (d, J = 9.4 Hz, 1H); 7.64 (d, J = 9.4 Hz, 1H), 7.11
(d, J = 8.6 Hz, 1H); 6.50 (br.s, 2H, two signals overlapped); 3.07 (s, 6H), 2.65 (s, 6H); 13C-NMR (CDCl3:
100.56 MHz, 25 ◦C):
δ (ppm): 152.9; 152.1; 149.0; 148.9; 144.3; 140.8; 136.4; 132.8; 131.4; 127.5; 119.1;
107.7; 103.5; 43.3; 41.2; ESI-MS (m/z): 328 [M + H]+, 350 [M + Na]+, 366 [M + K]+; HRMS (ES+) m/z:
[M + H]+ calculated for C16H18N5O3 328.1410 found 328.1413.
7-(2,4-Di(piperidin-1-yl)phenyl)-4,6-nitrobenzo[c][1,2,5]oxadiazole-1-oxide (19): eluent: ethyl ether/petroleum
light 1/1; yield 80%; brown solid, m.p.: >280 ◦C (dec); IR (v, cm−1): 1610, 1554, 1520, 1312;1H-NMR
(CDCl3, 400 MHz, 25 ◦C):
δ (ppm): 8.80 (s, 1H); 7.66 (d, J = 9.7 Hz, 2 H, two signals overlapped); 6.66
(br.s, 1H); 3.43–3.30 (m, 4H); 2.91–2.75 (m, 4H); 1.77 (br.s, 2H); 1.69 (s, 2H); 1.49 (br.s, 4H); ESI-MS (m/z):
469 [M + H]+, 491 [M + Na]+, 507 [M + K]+; HRMS (ES+) m/z: [M + H]+ calculated for C22H25N6O6
469.1836 found 469.1838.
7-(2,4-Di(morpholin-1-yl)phenyl)-4,6-nitrobenzo[c][1,2,5]oxadiazole-1-oxide (20): eluent: ethyl acetate/n-hexane
◦
7/3; yield 80%; brown solid, m.p.: >280 C (dec); IR (v, cm−1): 1607, 1549, 1515, 1313; 1H-NMR (CDCl3,
400 MHz, 25 ◦C):
δ (ppm): 8.77 (s, 1H); 7.00 (d, J = 9.0 Hz, 1H); 6.67 (dd, J1 = 8.5 Hz, J2 = 1.8 Hz, 1H);
6.62 (d, J = 1.85 Hz, 1H); 3.87 (t, J = 4.6 Hz, 4H); 3.50–3.39 (m, 4H); 3.35 (t, J = 4.6 Hz, 4H); 2.97–2.78
(m, 4H); 13C-NMR (CDCl3: 100.56 MHz, 25 ◦C):
δ (ppm): 154.3; 153.9; 144.3; 142.1; 134.1; 133.9; 131.1;
127.7; 113.7; 111.8; 110.3; 105.5; 67.0; 66.3; 52.8; 47.8. ESI-MS (m/z): 473 [M + H]+, 495 [M + Na]+, 511
[M + K]+; HRMS (ES+) m/z: [M + H]+ calculated for C20H21N6O8 473.1421 found 473.1423.
7-(2,4-Di(pyrrolidin-1-yl)phenyl)-4,6-nitrobenzo[c][1,2,5]oxadiazole-1-ozide (21): eluent: ethyl ether/petroleum
light 1/1; yield 65%; brown solid, m.p.: >250 ◦C (dec); IR (v, cm−1): 1609, 1546, 1516, 1313; 1H-NMR
(CDCl3, 400 MHz, 25 ◦C):
δ (ppm): 8.85 (s, 1H); 7.01 (d, J = 8.7 Hz, 1H); 6.75 (d, J = 8.7 Hz, 1H); 6.72
(br.s, 1H); 3.68–3.59 (m, 4H); 4.48–3.41 (m, 4H); 2.17–2.05 (m, 8H); ESI-MS (m/z): 441 [M + H]+, 463
[M + Na]+; HRMS (ES+) m/z: [M + H]+ calculated for C20H21N6O6 441.1523 found 441.1526.
7-(2,4-Bis(dimethylamino)phenyl)-4,6-nitrobenzo[c][1,2,5]oxadiazole-1-ozide (22): eluent: ethyl ether/petroleum
light 8/2; yield 65% (70% in presence of Al2O3); brown solid, m.p.: >130 ◦C (dec); IR (v, cm−1): 1612,
◦
1545, 1510, 1314; 1H-NMR (CDCl3, 400 MHz, 25 C):
δ (ppm): 8.88 (s, 1H); 7.66 (d, J = 8.9 Hz, 1H); 6.56
(dd, J1 = 8.8 Hz, J2 = 2.1 Hz, 1H); 6.35 (s, 1H); 3.14 (s, 6H), 2.54 (s, 6H); 13C-NMR (CDCl3: 100.56 MHz,
(ppm): 154.1; 151.8; 143.2; 142.3; 134.2; 133.5; 131.4; 128.2; 111.3; 107.2; 102.4; 43.2; 40.2; ESI-MS
(m/z): 389 [M + H]+, 411 [M + Na]+; HRMS (ES+) m/z: [M + H]+ calculated for C16H17N6O6 389.1210
◦
25 C):
δ
found 389.1211.